Alaunos Therapeutics, Inc. (TCRT)
2.72
+0.12
(+4.70%)
USD |
NASDAQ |
Feb 20, 16:00
2.57
-0.15
(-5.51%)
After-Hours: 20:00
Alaunos Therapeutics EPS Diluted (Quarterly) : -0.5502 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.159M |
| Total Expenses (Quarterly) | 1.159M |
| Enterprise Value | 4.132M |
| Earnings Yield | -84.95% |
| Normalized Earnings Yield | -84.47 |